Today's Top 20 Gastroenterology and Endoscopy Stories
-
CRH Medical to lose client, GI studies — 3 GI industry notes
Here are three updates on GI companies and practices: -
Manage My SurgeryⓇ Enhances Patient Satisfaction and Increases Practice Efficiency at UVA Health
Higgs Boson Health has partnered with UVA Health to provide patients undergoing GI Endoscopy with the Manage My Surgery digital health platform. -
Dr. Chris Shaver's 8 predictions for GI in 2021
Chris Shaver, MD, is the CEO at Birmingham (Ala.) Gastroenterology Associates. Here, he offers eight predictions on the future of the specialty in 2021: -
5 most-read GI stories in 2020
These are the stories that made the biggest splash on Becker's ASC Review's gastroenterology line in 2020: -
GI in 2021 — What 6 gastroenterologists think is in store for the specialty
As a year unlike any other comes to a close, several trends emerged in gastroenterology over the past year that will continue to emerge in 2021. Here, six gastroenterologists share their predictions on the future of the specialty: -
Follow-up CRC care affected by disparities
Patients from certain ethnic groups with colorectal cancer may be unable to access follow-up care, according to a study published in Cancer. -
Population-based risk scores could improve risk predictions for IBD, study says
New York City-based Mount Sinai researchers built risk scores that improve prediction of inflammatory bowel disease risk, according to a Dec. 24 news release. -
44 GI centers that opened or were announced in 2020, by state
Here's a state-by-state breakdown of the 44 gastroenterology centers that opened or were announced in 2020: -
CRH Medical to lose 'significant' client
Atlanta-based United Digestive didn't renew its professional services agreement with CRH Medical, and its contract will expire Oct. 31, 2021, CRH announced Dec. 22. -
Top GI articles — Compensation, PE investment & more
Here are the most-read GI articles during the week of Dec. 21-25: -
GI Alliance expands footprint — 4 GI industry notes
Here are four updates from GI companies and practices over the past week: -
3 details on NYU Langone's new IBD center
New York University Langone Health opened a new, comprehensive IBD center for adults with Crohn's disease and ulcerative colitis, according to a Dec. 22 news release. -
The biggest year to date — Why 2 analysts think big things are in store for GI M&A in 2021
Private equity investment in the gastroenterology space has recovered from COVID-19-related delays and is on fire to end 2020. So, what's in store for 2021? -
The loophole is closing — Congress includes colonoscopy loophole bill in COVID-19 relief package
The Removing Barriers to Colorectal Cancer Screening Act of 2020 passed the U.S. House Dec. 9 and was included in the COVID-19 relief bill the Senate cleared Dec. 21. -
6 things to know about PE investment in GI over the last 90 days
COVID-19 disrupted private equity investment in the gastroenterology space but as the year comes to a close, practices are flocking to PE money establishing new platforms and growing established platforms. -
GI Alliance acquires Louisiana group with 26 GIs
Dallas-based GI Alliance expanded its Louisiana presence Dec. 17 through the acquisition of Metropolitan Gastroenterology Associates. -
GI Alliance expands into Mississippi, acquires GI Associates
Dallas-based GI Alliance partnered with Gastrointestinal Associates in Jackson, Miss., expanding its presence into an eighth state, the platform announced Dec. 17. -
How GI compensation changed over the last decade
Gastroenterologist compensation will be affected by COVID-19, ending a generally upward trend from the last several years. -
Top-read GI articles — IBD patients and COVID-19, new Florida practice and more
Here are the most-read GI articles from Dec. 14-18: -
Takeda receives priority review for eosinophilic esophagitis treatment
The FDA accepted Takeda's new drug application for TAK-721, its eosinophilic esophagitis treatment, the company announced Dec. 15.